Vitality Watch

Dossier pubmed observational 10-nov-2026
Human cohort, case-control, or epidemiological association

Associations between sarcopenic obesity subtypes, cognitive function and neurodegenerative diseases risk in middle-aged and older adults.

Key claim: Sarcopenic obesity comprises distinct phenotypic subtypes, with a covert sarcopenia and muscle strength imbalance subtype conferring greater cognitive impairment than metabolic burden alone.

Abstract

PURPOSE/AIMS: This study aimed to identify subtypes of sarcopenic obesity (SO) in middle-aged and older adults and examine their associations with cognitive function and the risk of incident neurodegenerative diseases (NDs), to inform subtype-specific screening. METHODS: We utilized data from the China Health and Retirement Longitudinal Study (CHARLS), with baseline in 2011 and follow-up through 2020, incorporating 1,010 middle-aged and older adults with SO. Latent class analysis (LCA) was used to identify SO subtypes. Cross-sectional associations of subtypes and cognitive function were examined using linear regression models, and Cox proportional hazards models were applied to evaluate association with incident NDs. RESULTS: Three SO subtypes were identified: Covert sarcopenia-muscle strength imbalance (CS-MSI), Low metabolic burden-muscle maintenance (LMB-MM), and High metabolic burden-inflammation driven (HMB-ID). Compared with LMB-MM, the CS-MSI subtype had lower performance across multiple cognitive domains, whereas the HMB-ID subtype showed a comparatively prominent decrement in orientation (β = -1.12, 95% CI: -1.66 to -0.58). Longitudinally, the CS-MSI subtype showed a directionally higher but non-significant hazard of incident NDs. CONCLUSIONS: Distinct SO subtypes were associated with different cognitive profiles. Recognizing the CS-MSI subtype, which conventional obesity- and metabolism-based screening would miss, may improve early identification of middle-aged and older adults at risk, pending validation in independent cohorts.

Why this matters

[human-observational] This CHARLS analysis associates distinct sarcopenic-obesity phenotypes with different cognitive profiles, with poorer multi-domain performance in the covert-sarcopenia and muscle-strength-imbalance subtype than in high-metabolic-burden phenotypes. [human-observational] The finding extends the muscle-function–cognition association but leaves reverse causation and residual confounding unresolved; it does not establish that improving strength prevents cognitive decline or identify an effective training protocol.

Source

Link

Briefing card

Associations between sarcopenic obesity subtypes, cognitive function and neurodegenerative diseases risk in middle-aged and older adults.
Stage: observational · pubmed · 10-nov-2026

[human-observational] If you have sarcopenic obesity, this cohort analysis links its covert-sarcopenia and muscle-strength-imbalance subtype with poorer cognitive performance than high-metabolic-burden subtypes, without showing that the muscle phenotype causes cognitive decline.

Sarcopenic obesity comprises distinct phenotypic subtypes, with a covert sarcopenia and muscle strength imbalance subtype conferring greater cognitive impairment than metabolic burden alone.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.gerinurse.2026.104418

build build 880 · 2bcef25 · 2026-11-18